Sabby Management, LLC Ampio Pharmaceuticals, Inc. Transaction History

Sabby Management, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2019 Nov 15, 2019	SELL	$0.38 - $0.52 $2 Million - $2.74 Million	-5,265,265 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$0.39 - $0.7 $2.05 Million - $3.69 Million	5,265,265 New	5,265,265 $2.04 Million

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sabby Management, LLC with notifications on news.